Dopamine-induced inhibition of synaptic transmission in lumbar paravertebral ganglia of the dog.
D000081:Acetamides / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004874:Ergonovine / Q000494:pharmacology; D005727:Ganglia, Spinal / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008697:Methane / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology
D000081:Acetamides; D000959:Antihypertensive Agents; D002090:Butyrophenones; D002395:Catecholamines; D010880:Piperidines; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D010868:Pimozide; D006220:Haloperidol; D007545:Isoproterenol; D001058:Apomorphine; D008697:Methane; D002746:Chlorpromazine; D004298:Dopamine; D004874:Ergonovine; D009638:Norepinephrine; D010646:Phentolamine